Brittany de Temple

Brittany de Temple is the SVP of Development Operations at Braveheart Bio, bringing over 20 years of experience in global clinical development and operational leadership across large biopharma and emerging biotech companies. Prior to Braveheart, Brittany spent seven years at Akero Therapeutics, where she played a key role in scaling the company from a pre-IPO startup to a public, late-stage organization. As VP of Development Operations, she built and led a high-performing clinical development operations organization and oversaw execution of Akero’s global Phase 3 MASH program. Earlier in her career, she held leadership roles at IQVIA and Genentech, managing complex global oncology programs, and began her industry experience at Gilead Sciences supporting global HIV and HCV development programs.  Brittany holds a B.S. in Biochemistry from the University of California, Los Angeles, and is a certified Project Management Professional (PMP).